Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Seres Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 154 | 147 | −7 |
| Shares | 90.0M | 86.4M | −3.60M (−4.0%) |
| Value | $1.85B | $1.93B | +$74.2M (+4.0%) |
New holders (21)
Institutions that held Seres Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 106,602 | $2.54M | 0.03% |
| Integral Health Asset Management, LLC | 75,000 | $1.79M | 0.49% |
| Asymmetry Capital Management, L.P. | 63,259 | $1.51M | 1.04% |
| Caption Management, LLC | 62,936 | $1.50M | 0.13% |
| Sit Investment Associates Inc | 62,450 | $1.49M | 0.04% |
| HighVista Strategies LLC | 44,750 | $1.07M | 0.76% |
| CSS LLC | 44,240 | $1.05M | 0.06% |
| Hennion & Walsh Asset Management, Inc. | 34,301 | $818.0K | 0.04% |
| Connor, Clark & Lunn Investment Management Ltd. | 31,657 | $755.0K | 0.00% |
| Pura Vida Investments, LLC | 30,000 | $716.0K | 0.05% |
| Cubist Systematic Strategies, LLC | 27,691 | $660.0K | 0.01% |
| Blueshift Asset Management, LLC | 22,724 | $542.0K | 0.03% |
| Belvedere Trading LLC | 23,532 | $488.0K | 0.20% |
| Vontobel Holding Ltd. | 13,774 | $329.0K | 0.00% |
| Raymond James & Associates | 13,203 | $315.0K | 0.00% |
| Amalgamated Bank | 13,143 | $313.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 11,484 | $274.0K | 0.07% |
| Walleye Trading LLC | 11,105 | $265.0K | 0.01% |
| FORA Capital, LLC | 3,935 | $94.0K | 0.02% |
| US Bancorp | 31 | $1.00K | 0.00% |
| TD Private Client Wealth LLC | 38 | $906 | 0.00% |
Sold out (28)
Institutions that held Seres Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.